InDevR is a global leader in progressive new analytical technologies that enable accelerated development and manufacturing of vaccines and other biotherapeutics. Key products include our VaxArray portfolio of our game-changing multiplexed potency assays for vaccines and the Cypher One system for digital imaging and automated interpretation of hemagglutination assays.
Location: United States, Colorado, Boulder
Employees: 51-200
Total raised: $16M
Founded date: 2003
Investors 1
| Date | Name | Website |
| - | Adjuvant C... | adjuvantca... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 18.01.2023 | Series B | $9M | - |
| 12.09.2019 | Series A | $7M | - |
Mentions in press and media 7
| Date | Title | Description |
| 30.09.2024 | Measuring Intact mRNA and 5' Capping Efficiency in One Assay, Upcoming Webinar Hosted by Xtalks | www.indevr.com In this free webinar, learn how a multiplexed imaging platform can be used to determine mRNA capping and address mRNA vaccine drug product characterization requirements. Attendees will gain insights into rapidly measuring int... |
| 26.06.2024 | Streamline Serological Testing Using Multiplexed Assays that Generate Multiple Results in a Single Test, Upcoming Webinar Hosted by Xtalks | www.indevr.com In this free webinar, learn about a unique platform for serological testing that streamlines validated analytical assays with faster, more reliable results. Attendees will be introduced to the VaxArray Platform and its key ad... |
| 18.01.2023 | InDevR raises $9 Million in Series B Financing and Partners with bioMérieux | Boulder, Colorado, United States InDevR, Inc., a provider of best-in-class analytical technologies for vaccines and biotherapeutics, announced that it has raised $9 million in series B financing. Adjuvant Capital has invested $4 million, an... |
| 01.07.2021 | InDevR Launches VaxArray Polio Kit for Faster, Multiplexed Vaccine Characterization | BOULDER, Colo., July 1, 2021 /PRNewswire/ -- InDevR, Inc., a life science tools company providing powerful analytical technologies to support the development and production of vaccines and biotherapeutics, announced commercial availability ... |
| 12.09.2019 | InDevR Raises $7M Series A Financing | BOULDER, CO, InDevR today announced that it has raised a $7 million Series A round. >> Click here for more funding data on InDevR >> To export InDevR funding data to PDF and Excel, click here InDevR, a biotechnology compa... |
| 10.09.2019 | InDevR Raises $7M in Series A Financing | InDevR, Inc., a Boulder, CO-based biotechnology company focused on developing and commercializing novel analytical technologies for biologic process development and monitoring, raised $7m in Series A round of equity financing. Adjuvant Capi... |
| - | InDevR | “A team of researchers at USAMRIID presented a poster at […]” |